Company Update Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Marksans Pharma Limited''s wholly owned subsidiary in the UK, Relonchem Limited received Marketing Authorisation for its product Oxybutynin Hydrochloride 2.5mg/5ml oral solution from UK MHRA